Second Canadian medical cannabis firm target of class-action suit
A second Canadian medical cannabis producer embroiled in a controversy over tainted marijuana is the target of a proposed class-action lawsuit by patients who unwittingly consumed prohibited pesticides.
According to the Globe and Mail, Mettrum, in addition to OrganiGram, was found selling MMJ containing pesticide myclobutanil, which emits hydrogen cyanide that, when lit, and can cause serious health problems.
A court must certify the proposed lawsuits targeting the federally licensed producers before they can proceed.
The suit against Mettrum was filed in Ontario Supreme Court, while the separate OrganiGram suit was filed earlier in Nova Scotia Supreme Court, the
Second Canadian medical cannabis firm target of class-action suit is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs